Open Calls for Input and Feedback


Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.

At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.

Draft Recommendations

MAR-Trientine (Trientine Hydrochloride)

Therapeutic Area: Wilson's Disease
Draft recommendations posted for stakeholder feedback: October 14, 2021
End of feedback period: October 28, 2021
Draft Recommendation

Submit Feedback

 

Evenity (romosozumab)

Therapeutic Area: Osteoporosis, postmenopausal women
Draft recommendations posted for stakeholder feedback: October 14, 2021
End of feedback period: October 28, 2021
Draft Recommendation

Submit Feedback

 

 

Open Calls for Patient and Clinician Input

Therapeutic Area
Therapeutic Area: advanced or metastatic renal cell carcinoma
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Lambert-Eaton Myasthenic Syndrome, adults
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Diffuse large B-cell lymphoma (DLBC)
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Schizophrenia
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Dyspareunia, vaginal dryness
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Gastrointestinal stromal tumours
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Thyroid cancer
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Endometrial cancer
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Neurotrophic keratitis
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Severe Alpha1-proteinase inhibitor deficiency
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed: